<p>(A) In intestinal-type gastric cancer patients, the heterozygous variant genotype (AC) did not show significant association with survival outcomes; (B) In diffuse-type gastric cancer patients, individuals with the AC genotype had a significantly increased risk of death when compared with those carrying the homozygous variant genotypes (AA/CC). HR and 95% CIs were estimated using multivariate Cox regression model. Statistical differences between two survival curves were assessed by the log-rank test. Asterisks (*) indicates mean OS when median OS could not be calculated. <sup>†</sup>The log-rank <i>P</i> value less than 0.05 was corrected by a permutation test (n = 5000 random permutations) reported by Vasselli et al <a href="http://www.p...
*<p>The adjusted HR and <i>P</i> value reported in <a href="http://www.plosone.org/article/info:doi/...
was reported to induce the risk of breast cancer. In this study, we hypothesized that rs3803662 cou...
The main treatment for advanced gastric cancer is fluoropyrimidine and platinum-based chemotherapy. ...
<p>OS: overall survival; HR: hazard ratio; CI: confidence interval.</p><p>*Mean OS was presented whe...
Objectives: Genome-wide association studies (GWAS) have demonstrated that the single nucleotide poly...
OBJECTIVES: Genome-wide association studies (GWAS) have demonstrated that the single nucleotide poly...
<p>Stratified analysis of <i>MAP3K1 rs889312</i> genotypes associated with survival outcomes in diff...
SNPs in clinical outcomes in gastric cancer patients. genotypes and haplotypes on clinical outcomes...
*<p><i>P</i> values were calculated by Cox proportional hazards model using univariate analysis.</p>...
Backgrounds: Genome-wide association studies (GWASs) have identified several gastric cancer (GC) sus...
*<p>Haplotype was composed in the order of rs1799793, rs13181, rs3213986; G-T-G was the most common ...
<p>Overall survival of <i>TOX3</i> rs3803662 dominant genotypes in diffuse-type gastric cancer patie...
Immunomodulator-targeting therapies are under development in gastric cancer (GC). However, the role ...
cause of cancer-related deaths worldwide, accounting for 738,000 deaths annually [1]. Gastric cancer...
<p>Overall survival of <i>TOX3</i> rs3803662 dominant genotypes in intestinal-type gastric cancer pa...
*<p>The adjusted HR and <i>P</i> value reported in <a href="http://www.plosone.org/article/info:doi/...
was reported to induce the risk of breast cancer. In this study, we hypothesized that rs3803662 cou...
The main treatment for advanced gastric cancer is fluoropyrimidine and platinum-based chemotherapy. ...
<p>OS: overall survival; HR: hazard ratio; CI: confidence interval.</p><p>*Mean OS was presented whe...
Objectives: Genome-wide association studies (GWAS) have demonstrated that the single nucleotide poly...
OBJECTIVES: Genome-wide association studies (GWAS) have demonstrated that the single nucleotide poly...
<p>Stratified analysis of <i>MAP3K1 rs889312</i> genotypes associated with survival outcomes in diff...
SNPs in clinical outcomes in gastric cancer patients. genotypes and haplotypes on clinical outcomes...
*<p><i>P</i> values were calculated by Cox proportional hazards model using univariate analysis.</p>...
Backgrounds: Genome-wide association studies (GWASs) have identified several gastric cancer (GC) sus...
*<p>Haplotype was composed in the order of rs1799793, rs13181, rs3213986; G-T-G was the most common ...
<p>Overall survival of <i>TOX3</i> rs3803662 dominant genotypes in diffuse-type gastric cancer patie...
Immunomodulator-targeting therapies are under development in gastric cancer (GC). However, the role ...
cause of cancer-related deaths worldwide, accounting for 738,000 deaths annually [1]. Gastric cancer...
<p>Overall survival of <i>TOX3</i> rs3803662 dominant genotypes in intestinal-type gastric cancer pa...
*<p>The adjusted HR and <i>P</i> value reported in <a href="http://www.plosone.org/article/info:doi/...
was reported to induce the risk of breast cancer. In this study, we hypothesized that rs3803662 cou...
The main treatment for advanced gastric cancer is fluoropyrimidine and platinum-based chemotherapy. ...